Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Sale | 2024-04-03 6:18 pm | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 9,961 | $6.6283 | $66,024 | 3,452,329 (Indirect Direct) | View |
| 2024-02-20 Sale | 2024-02-22 7:04 pm | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 15,701 | $7.6048 | $119,403 | 3,462,290 (Indirect Direct) | View |
| 2024-01-02 Sale | 2024-01-04 6:09 pm | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 10,691 | $7.407 | $79,188 | 3,477,991 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-09 Option Award | 2024-01-11 6:42 pm | N/A 2034-01-08 | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 1,378,327 | $0 | 1,378,327 (Direct) | View |
| 2023-10-04 Other | 2023-10-06 5:55 pm | N/A N/A | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 1,293,983 | $0 | 4,781,372 (Indirect) | View |
| 2023-08-16 Option Award | 2023-08-18 6:49 pm | N/A N/A | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 842,400 | $0 | 4,516,900 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-19 6:31 pm | 2023-06-18 2033-05-18 | Surrozen Inc. | SRZN | Lin Shao-Lee Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-09 Tax Withholding | 2023-05-11 8:50 pm | N/A N/A | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 337,179 | $24.69 | 7,249,756 (Direct) | View |
| 2023-05-09 Other | 2023-05-11 8:50 pm | N/A 2033-05-03 | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 4,044,539 | $0 | 7,249,756 (Direct) | View |
| 2023-05-09 Conversion | 2023-05-11 8:50 pm | N/A N/A | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 2,323,494 | $0 | 7,249,756 (Indirect) | View |
| 2023-05-04 Option Award | 2023-05-04 7:57 pm | N/A 2033-05-03 | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 774,788 | $0 | 774,788 (Direct) | View |
Ownership | 2023-05-04 6:43 pm | N/A N/A | ACELYRIN Inc. | SLRN | Lin Shao-Lee Chief Executive Officer | 0 | $0 | 4,011,679 (Direct) | View |
| 2022-10-26 Option Award | 2022-10-27 4:57 pm | N/A 2032-10-25 | Third Harmonic Bio Inc. | THRD | Lin Shao-Lee Director | 13,667 | $0 | 13,667 (Direct) | View |
Ownership | 2022-09-14 6:15 pm | N/A 2030-09-13 | Third Harmonic Bio Inc. | THRD | Lin Shao-Lee Director | 0 | $0 | 95,259 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 5:49 pm | 2023-06-07 2032-06-07 | Surrozen Inc. | SRZN | Lin Shao-Lee Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2021-08-16 7:47 pm | N/A N/A | Surrozen Inc. | SRZN | Lin Shao-Lee Director | 0 | $0 | 35,129 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:25 pm | N/A 2029-04-15 | Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director | 40,955 | $0 | 0 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:05 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-01-21 Option Award | 2020-01-23 4:22 pm | N/A N/A | Horizon Therapeutics Public Ltd Co | HZNP | Lin Shao-Lee EVP, Head of R&D and CSO | 18,391 | $0 | 121,930 (Direct) | View |
| 2020-01-21 Tax Withholding | 2020-01-23 4:22 pm | N/A N/A | Horizon Therapeutics Public Ltd Co | HZNP | Lin Shao-Lee EVP, Head of R&D and CSO | 2,716 | $38.25 | 121,930 (Direct) | View |
| 2020-01-04 Exercise | 2020-01-07 6:21 pm | N/A N/A | Horizon Therapeutics Public Ltd Co | HZNP | Lin Shao-Lee EVP, Head of R&D and CSO | 118,580 | $0 | 246,652 (Direct) | View |
| 2020-01-04 Tax Withholding | 2020-01-07 6:21 pm | N/A N/A | Horizon Therapeutics Public Ltd Co | HZNP | Lin Shao-Lee EVP, Head of R&D and CSO | 46,213 | $36.1 | 246,652 (Direct) | View |
| 2020-01-03 Option Award | 2020-01-07 6:21 pm | N/A N/A | Horizon Therapeutics Public Ltd Co | HZNP | Lin Shao-Lee EVP, Head of R&D and CSO | 71,936 | $0 | 246,652 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-11 6:57 pm | N/A 2029-06-10 | Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director | 10,240 | $0 | 10,240 (Direct) | View |